manufacturing

Antibody production on a commercial scale, at a fraction of the capital cost, with shorter lead times, and greater flexibility.

Tour of XBiotech modular cleanrooms where True Human™ antibody therapies are produced.

WHAT ARE TRUE HUMAN™ ANTIBODIES?

White blood cells in the human body secrete billions of different antibodies that circulate through the blood to react and protect us from toxins, infectious agents or even other unwanted substances produced by our body.

True Human™ antibodies, as the name implies, are simply those that are derived from a natural antibody identified from the blood of an individual. 

TRUE HUMAN™ ANTIBODIES

State-of-the-art made simple. Engineered, designed and developed at XBiotech.

At XBiotech, we believe that cutting-edge medicine should work in a targeted way to make patients feel better and help restore quality of life without worry of side effects. Through True Human™ technology, we want to be pioneers in the way the world looks at biopharmaceutical technology and production. 

We have established a Start-to-Finish monoclonal antibody production platform. From the construction of Production Cell Banks to the Aseptic Fill of Vials and Pre-filled Syringes, all production processes are performed on-site in our manufacturing facility utilizing disposable single use systems.

Our production platform allows for the rapid scale-up of new investigational molecules and their associated cGMP processes, while our talented and experienced multi-disciplinary manufacturing team leads the finalization in process design, implements continuous process development, and generates clinic-ready production batches.

manufacturing

Industry Context

Until now each and every therapeutic antibody on the market has been derived from animals and/or through gene sequence modification in the laboratory to produce a desired antibody reactivity.

Marketed antibodies to date, described as “Fully Human”, are not derived from human gene sequences that have undergone the crucial process of selection in a human. Without exception, all marketed products to date that are described as “Fully Human”, are in fact engineered and are not selected based on natural tolerance in the human body. The use of the term “Fully Human” to describe these products has thus created considerable confusion.

TRUE HUMAN™ ANTIBODIES

A True Human™ Monoclonal Antibody Should Therefore Not Be Confused With Other Marketed Therapeutic Monoclonal Antibodies, Such As Those Currently Referred To As “Fully Human” Antibodies.

TRUE HUMAN™ ANTIBODIES

manufacturing

XBiotech’s GMP audited manufacturing facility.

The clean-room environment (meets ISO 14644-1:2015 Class 7 and Class 5 air quality standards) is 20,442 square feet with 18,537 square feet of manufacturing support areas including controlled-access raw materials receiving/quarantine area, a controlled-access released goods storage and quality control and microbiology laboratories.

manufacturing